Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Episode | Date |
---|---|
Episode 24: Myeloma Madness with the Myeloma Man
|
Apr 17, 2024 |
Anthony and Bernie get rich on no-larabine! An ASH 2023 ALL discussion
|
Jan 25, 2024 |
LymphOMG: Pouring Over Lymphoma Abstracts from ASH
|
Dec 29, 2023 |
AMLchemy at ASH: Brewing Success with Menin Magic, MRD Mysteries, and Aza/Ven Alchemy
|
Dec 19, 2023 |
ASH Pregaming - Myeloma Madness with Manni and Papa Heme
|
Dec 01, 2023 |
AML Maintenance Part 2: a metaMORPHOsis?
|
Nov 08, 2023 |
AML Maintenance Part 1: Set Your QUAZARs to Stun
|
Oct 25, 2023 |
Episode 17: The Hemophilia Eras Tour
|
Aug 23, 2023 |
Common Sense Oncology: Outcomes That Matter
|
Aug 01, 2023 |
All too well: the reality of leukemia treatment
|
Jun 08, 2023 |
Episode 14: A Quantum Leap in AML Treatment? Dissecting Quizartinib Data with Dr. Dale Bixby
|
May 09, 2023 |
Episode 13: You get blinatumomab! You get blinatumomab!
|
Feb 24, 2023 |
Episode 12: Tinder for T Cells - Bispecifics in DLBCL
|
Feb 08, 2023 |
Episode 11: "Olu the Drunk Snowman" - IDH inhibitors in R/R AML with Dr. Jill Lykon
|
Jan 21, 2023 |
Episode 10: ASH Recap Part 2 - Papa Heme + WolverHeme
|
Dec 21, 2022 |
Episode 9: ASH Recap Part 1 - Dauno-Double Trouble
|
Dec 14, 2022 |
Episode 8: Pulling the Goalie on FLT3 Inhibitor Use in AML - A Discussion with Dr. Dale Bixby
|
Nov 23, 2022 |
Episode (3+)7: Straight Outta Roswell - OG AML Data
|
Oct 07, 2022 |
Episode 6: Dr. StrangeDrug or: How I Learned to Stop Worrying and Love the Asparaginase
|
Jul 21, 2022 |
Episode 5: IDH Inhibitors in AML: not so AGILE
|
Jun 03, 2022 |
Episode 4: All Aboard the Oncology StewardSHIP
|
May 27, 2022 |
Episode 3.2: Ranting About Rituximab in Acute Lymphoblastic Leukemia
|
Apr 22, 2022 |
Episode 3.1: History of Acute Lymphoblastic Leukemia Treatment and Building the BFM Backbone
|
Apr 22, 2022 |
Episode 2: We Don't Talk About Rylaze
|
Mar 18, 2022 |
Episode 1: Surrogate Endpoints in AML
|
Mar 11, 2022 |